Literature DB >> 3046975

Alloxan: history and mechanism of action.

S Lenzen1, U Panten.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 3046975     DOI: 10.1007/BF02341500

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  57 in total

1.  Protective effects of glutathione and cysteine against alloxan diabetes in the rat.

Authors:  A LAZAROW
Journal:  Proc Soc Exp Biol Med       Date:  1946-04

2.  Further observations on the effects of alloxan on the pancreatic islets.

Authors:  J S Dunn; E Duffy; M K Gilmour; J Kirkpatrick; N G McLetchie
Journal:  J Physiol       Date:  1944-09-29       Impact factor: 5.182

3.  Alloxan and dialuric acid; their stabilities and ultraviolet absorption spectra.

Authors:  J W PATTERSON; A LAZAROW
Journal:  J Biol Chem       Date:  1949-01       Impact factor: 5.157

4.  Reversal of the diabetogenic action of alloxan by sulfhydryl compounds.

Authors:  P B SEN; G BHATTACHARYA
Journal:  Science       Date:  1952-01-11       Impact factor: 47.728

5.  Sequencing a protein by x-ray crystallography. II. Refinement of yeast hexokinase B co-ordinates and sequence at 2.1 A resolution.

Authors:  C M Anderson; R E Stenkamp; T A Steitz
Journal:  J Mol Biol       Date:  1978-07-25       Impact factor: 5.469

6.  Molecular requirements for recognition at glucoreceptor for insulin release.

Authors:  D C Weaver; C D Barry; M L McDaniel; G R Marshall; P E Lacy
Journal:  Mol Pharmacol       Date:  1979-09       Impact factor: 4.436

7.  Glucose and alloxan interactions in the pancreatic islets.

Authors:  W S Zawalich; L M Beidler
Journal:  Am J Physiol       Date:  1973-04

Review 8.  Drugs producing diabetes through damage of the insulin secreting cells.

Authors:  C C Rerup
Journal:  Pharmacol Rev       Date:  1970-12       Impact factor: 25.468

9.  Noncarbohydrate nutrients protect against alloxan-induced inhibition of insulin release.

Authors:  A Sener; F Malaisse-Lagae; W J Malaisse
Journal:  Endocrinology       Date:  1982-06       Impact factor: 4.736

10.  Alloxan effects on mitochondria: study of oxygen consumption, fluxes of Mg2+, Ca2+, K+ and adenine nucleotides, membrane potential and volume change in vitro.

Authors:  L Boquist
Journal:  Diabetologia       Date:  1984-09       Impact factor: 10.122

View more
  32 in total

1.  Microsomal reduction of alloxan produces alloxan anion radicals.

Authors:  M Nukatsuka; H Sakurai; J Kawada
Journal:  Naturwissenschaften       Date:  1989-12

Review 2.  Implant healing in experimental animal models of diabetes.

Authors:  Nga N Le; Michael B Rose; Howard Levinson; Bruce Klitzman
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

3.  Blockade of muscarinic transmission increases the frequency of diabetes after low-dose alloxan challenge in the mouse.

Authors:  B Ahrén; G Sundkvist; H Mulder; F Sundler
Journal:  Diabetologia       Date:  1996-04       Impact factor: 10.122

4.  Intra-islet insulin permits glucose to directly suppress pancreatic A cell function.

Authors:  C J Greenbaum; P J Havel; G J Taborsky; L J Klaff
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 5.  Chemical and Biological Aspects of Extracts from Medicinal Plants with Antidiabetic Effects.

Authors:  Lucas F Gushiken; Fernando P Beserra; Ariane L Rozza; Patrícia L Bérgamo; Danilo A Bérgamo; Cláudia H Pellizzon
Journal:  Rev Diabet Stud       Date:  2016-08-10

Review 6.  The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.

Authors:  Richard D Semba; Hu Huang; Gerard A Lutty; Jennifer E Van Eyk; Gerald W Hart
Journal:  Proteomics Clin Appl       Date:  2014-02-19       Impact factor: 3.494

7.  A new immunodeficient hyperglycaemic mouse model based on the Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function.

Authors:  T Pearson; L D Shultz; J Lief; L Burzenski; B Gott; T Chase; O Foreman; A A Rossini; R Bottino; M Trucco; D L Greiner
Journal:  Diabetologia       Date:  2008-06-19       Impact factor: 10.122

8.  A small molecule that inhibits OGT activity in cells.

Authors:  Rodrigo F Ortiz-Meoz; Jiaoyang Jiang; Michael B Lazarus; Marina Orman; John Janetzko; Chenguang Fan; Damien Y Duveau; Zhi-Wei Tan; Craig J Thomas; Suzanne Walker
Journal:  ACS Chem Biol       Date:  2015-03-18       Impact factor: 5.100

9.  Inhibition of aconitase by alloxan and the differential modes of protection of glucose, 3-O-methylglucose, and mannoheptulose.

Authors:  S Lenzen; M Mirzaie-Petri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

10.  Macrophage function in alloxan diabetic mice: expression of adhesion molecules, generation of monokines and oxygen and NO radicals.

Authors:  W Ptak; M Klimek; K Bryniarski; M Ptak; P Majcher
Journal:  Clin Exp Immunol       Date:  1998-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.